| 2020-02-18 |
Impacts of intralipid on nanodrug abraxane therapy and on the innate immune system |
Scientific Reports. 2020 Feb 18;10:Article number 2838. |
 |
| 2020-02-10 |
Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-Dioxygenase inhibitors |
Journal of Medicinal Chemistry. 2020 Feb 10;63(4):1642-1659. |
|
| 2020-02-01 |
Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment |
European Journal of Medicinal Chemistry. 2020 Feb 1;187:Article number 111915. |
|
| 2020-02 |
The cardenolides ouabain and reevesioside A promote FGF2 secretion and subsequent FGFR1 phosphorylation via converged ERK1/2 activation |
Biochemical Pharmacology. 2020 Feb;172:Article number 113741. |
|
| 2020-02 |
Design, synthesis and anticancer evaluation of beta-carboline-1-one hydantoins |
Future Medicinal Chemistry. 2020 Feb;12(3):183-192. |
|
| 2020-02 |
Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1alpha |
Pharmacological Research. 2020 Feb;152:Article number 104581. |
|
| 2020-01-16 |
Development of a cross-conjugated vinylogous [4+2] anionic annulation and application to the total synthesis of natural antibiotic (±)-ABX |
Advanced Materials. 2020 Jan 16;132(16):6602-6607. |
|
| 2020-01-06 |
Biosynthetic engineering of the antifungal, anti-MRSA auroramycin |
Microbial Cell Factories. 2020 Jan 6;19:Article number 3. |
|
| 2020-01-01 |
Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and nonalcoholic fatty liver disease in mice |
British Journal of Pharmacology. 2020 Jan 1;177(2):239-253. |
|
| 2020-01 |
Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening |
Biochimie. 2020 Jan;168:220-230. |
|
| 2019-12-24 |
ERK activation modulates cancer stemness and motility of a novel mouse oral squamous cell carcinoma cell line |
Cancers. 2019 Dec 24;12(1):Article number 61. |
|
| 2019-12 |
Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry |
Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517. |
|
| 2019-12 |
A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses |
Antiviral Research. 2019 Dec;172:Article number 104636. |
|
| 2019-12 |
Progerin in muscle leads to thermogenic and metabolic defects via impaired calcium homeostasis |
Aging Cell. 2019 Dec;Article number e13090. |
|
| 2019-12 |
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia |
Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150. |
|
| 2019-11-27 |
Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer |
Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123. |
|
| 2019-10-08 |
Identification of two novel small compounds that inhibit liver cancer formation in zebrafish and analysis of their conjugation to nanodiamonds to further reduce toxicity |
Advanced Therapeutics. 2019 Oct 8;2(12):Article number 1900105. |
|
| 2019-10 |
In vivo efficacy of cannabinoid receptor 1 antagonist, CPD1, in treating non-alcoholic fatty liver disease |
Hepatology. 2019 Oct;70:1333A. |
|
| 2019-10 |
Discovery of clinical candidate DBPR112, a furanopyrimidine-based epidermal growth factor receptor inhibitor for the treatment of non-small cell lung cancer |
Annals of Oncology. 2019 Oct;30(Suppl. 5):789. |
|
| 2019-10 |
The molecular mechanisms of EpCAM in regulating tumor progression and development of anti-EpCAM antibodies for colon cancer diagnosis and therapy |
Annals of Oncology. 2019 Oct;30(Suppl. 5):786. |
|
| 2019-10 |
Inhibition of Rspo-Wnt pathway facilitates checkpoint blockade therapy by anti-RSPO3 antibody (DBPR117) |
Annals of Oncology. 2019 Oct;30(Suppl. 5):191. |
|
| 2019-09 |
Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1 |
Phytomedicine. 2019 Sep;62:Article number 152946. |
|
| 2019-08-27 |
A dengue virus type 2 (DENV-2) NS4B-interacting host factor, SERP1, reduces DENV-2 production by suppressing viral RNA replication |
Viruses. 2019 Aug 27;11(9):Article number 787. |
|
| 2019-08-15 |
Sun1 mediates interkinetic nuclear migration and Notch signaling in the neurogenesis of zebrafish |
Stem Cells and Development. 2019 Aug 15;28(16):1116-1127. |
|
| 2019-08-06 |
Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: An identification of a novel oncotarget[Erratum: Oncotarget. 2015 Feb;6(4):2148-2163.] |
Oncotarget. 2019 Aug 6;10(47):4919. |
|
